Park National Corp Pfizer Inc Transaction History

Park National Corp

$2.82 Billion
Q3 2024

A detailed history of Park National Corp transactions in Pfizer Inc stock. As of the latest transaction made, Park National Corp holds 106,657 shares of PFE stock, worth $2.85 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

106,657

Previous 203,064 47.48%

Holding current value

$2.85 Million

Previous $5.68 Million 45.68%

% of portfolio

0.11%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$27.7 - $31.39 $2.67 Million - $3.03 Million	-96,407 Reduced 47.48%	106,657 $3.09 Million
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $6.15 Million - $7.21 Million	-243,513 Reduced 54.53%	203,064 $5.68 Million
Q1 2024 Apr 01, 2024	SELL	$25.89 - $29.73 $615,249 - $706,503	-23,764 Reduced 5.05%	446,577 $12.4 Million
Q4 2023 Jan 02, 2024	BUY	$26.13 - $33.94 $594,771 - $772,542	22,762 Added 5.09%	470,341 $13.5 Million
Q3 2023 Oct 02, 2023	BUY	$32.09 - $37.51 $88,568 - $103,527	2,760 Added 0.62%	447,579 $14.8 Million
Q2 2023 Jul 03, 2023	SELL	$36.12 - $41.79 $73,431 - $84,959	-2,033 Reduced 0.45%	444,819 $16.3 Million
Q1 2023 Apr 03, 2023	BUY	$39.39 - $51.28 $489,105 - $636,743	12,417 Added 2.86%	446,852 $18.2 Million
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $347,193 - $453,222	-8,316 Reduced 1.88%	434,435 $22.3 Million
Q3 2022 Oct 03, 2022	BUY	$43.76 - $53.42 $1.26 Million - $1.53 Million	28,700 Added 6.93%	442,751 $19.4 Million
Q2 2022 Jul 01, 2022	SELL	$46.53 - $55.17 $196,868 - $233,424	-4,231 Reduced 1.01%	414,051 $21.7 Million
Q1 2022 Apr 01, 2022	BUY	$45.75 - $56.69 $391,711 - $485,379	8,562 Added 2.09%	418,282 $21.7 Million
Q4 2021 Jan 04, 2022	SELL	$41.32 - $61.25 $787,559 - $1.17 Million	-19,060 Reduced 4.45%	409,720 $24.2 Million
Q3 2021 Oct 01, 2021	SELL	$39.25 - $50.42 $2.19 Million - $2.81 Million	-55,702 Reduced 11.5%	428,780 $18.4 Million
Q2 2021 Jul 01, 2021	BUY	$35.91 - $40.68 $13,861 - $15,702	386 Added 0.08%	484,482 $19 Million
Q1 2021 Apr 01, 2021	BUY	$33.49 - $37.77 $168,119 - $189,605	5,020 Added 1.05%	484,096 $17.5 Million
Q4 2020 Jan 04, 2021	BUY	$33.47 - $42.56 $269,366 - $342,522	8,048 Added 1.71%	479,076 $17.6 Million
Q3 2020 Oct 01, 2020	BUY	$31.75 - $37.25 $20,161 - $23,653	635 Added 0.13%	471,028 $17.3 Million
Q2 2020 Jul 01, 2020	SELL	$30.12 - $36.54 $14,578 - $17,685	-484 Reduced 0.1%	470,393 $15.4 Million
Q1 2020 Apr 01, 2020	BUY	$27.03 - $38.62 $835,010 - $1.19 Million	30,892 Added 7.02%	470,877 $15.4 Million
Q4 2019 Jan 02, 2020	BUY	$32.92 - $37.36 $1.25 Million - $1.42 Million	38,062 Added 9.47%	439,985 $17.2 Million
Q3 2019 Oct 01, 2019	BUY	$32.49 - $42.13 $4.85 Million - $6.29 Million	149,377 Added 59.15%	401,923 $14.4 Million
Q2 2019 Jul 01, 2019	BUY	$36.98 - $41.52 $2.02 Million - $2.27 Million	54,642 Added 27.61%	252,546 $10.9 Million
Q1 2019 Apr 01, 2019	SELL	$37.5 - $41.2 $279,750 - $307,352	-7,460 Reduced 3.63%	197,904 $8.41 Million
Q4 2018 Jan 02, 2019	SELL	$38.47 - $43.86 $95,097 - $108,421	-2,472 Reduced 1.19%	205,364 $8.96 Million
Q3 2018 Oct 02, 2018	SELL	$34.47 - $41.81 $178,968 - $217,077	-5,192 Reduced 2.44%	207,836 $9.16 Million
Q2 2018 Jul 02, 2018	SELL	$32.98 - $35.16 $375,971 - $400,823	-11,400 Reduced 5.08%	213,028 $7.73 Million
Q1 2018 Apr 02, 2018	SELL	$31.91 - $37.02 $1.72 Million - $2 Million	-54,035 Reduced 19.4%	224,428 $7.97 Million
Q4 2017 Jan 02, 2018	SELL	$33.26 - $35.29 $755,201 - $801,294	-22,706 Reduced 7.54%	278,463 $10.1 Million
Q3 2017 Oct 02, 2017	BUY	$31.0 - $34.15 $9.34 Million - $10.3 Million	301,169	301,169 $10.8 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Account

Park National Corp Pfizer Inc Transaction History